论文部分内容阅读
获比尔·盖茨基金会资助、由葛兰素史克(GSK)公司研制的疟疾疫苗Mosquirix(又称RTS,S)是首个可有效预防致死率最高的恶性疟原虫疟疾的疫苗产品,是基于恶性疟原虫外膜蛋白和乙肝病毒片段并应用基因工程技术而制得,且其中还加入了可促
Mosquirix (also known as RTS, S), a malaria vaccine developed by GSK and sponsored by the Bill Gates Foundation, is the first vaccine product to effectively prevent malaria from Plasmodium falciparum, which has the highest mortality rate and is based on Plasmodium falciparum outer membrane protein and hepatitis B virus fragments and the application of genetic engineering technology and made, and also joined the can promote